Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
What is Adial Pharmaceuticals's quote symbol?
What is the 52 week high and low for Adial Pharmaceuticals (NASDAQ: ADIL)?
How much is Adial Pharmaceuticals stock worth today?
How much is Adial Pharmaceuticals's stock price per share?
What is Adial Pharmaceuticals's Market Cap?